Press release
Agenda released for SMi’s 19th Annual Superbugs European Show Featuring Keynotes from the FDA, BARDA and GSK
Superbugs and Superdrugs 2017
London’s flagship show in the global Superbugs portfolio of events has been expanding horizons on the growing threat of anti-microbial resistance (AMR) and infectious disease for almost two decades. It will once again provide a focal point for its growing “superbugs” community comprising of scientific leaders, funding bodies and drug discovery specialists, to network, exchange novel solutions and consolidate current strategies.
The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered by a panel of speakers who will hone in on key issues such as industry funding opportunities, the use of animal models in drug research and antimicrobial peptides.
Highlights will include a special regulatory spotlight on antibacterial drug development presented by Sumathi Nambiar, Director of the FDA Division of Anti-Infective Products.
Conference Chairmen, Richard Bax, Senior Partner from TranScrip; and Lloyd Czaplewski, Director of Chemical Biology Ventures said in a joint statement:
“In 2016 antimicrobial resistance achieved remarkable global attention. For a decade the community talked about the need for industry, academia and government to act on an international level to address the scientific challenges of antibiotic discovery, diagnosis, addressing the economics of antibiotics and to invest in unprecedented ways. In 2016 we may have witnessed change… Networking and learning with our peers is the secret to improving the drug development pipeline.”
Other notable speakers on the agenda for Superbugs & Superdrugs 2017 include:
Chris Houchens, Branch Chief, BARDA
James Anderson, Head of Corporate Government Affairs, GSK
Aileen Rubio, Head of Biology, Spero Therapeutics
David Williams, CEO, Discuva
Martin Everett, CSO, ANTABIO SAS
Jean de Gunzburg, Scientific Director, Da Volterra
William J Weiss, Dir, Pre-Clinical Services, UNT System College of Pharmacy
Further details including a full speaker line-up and detailed program are available at http://www.superbugssuperdrugs.com/openpr
For those looking to register, there is currently a £400 early bird saving available online which expires on 30th November 2016.
Superbugs & Superdrugs 2017
20th & 21st March,
Copthorne Tara Hotel, London UK
--- end ---
Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For delegate enquires contact Matthew Apps on Tel: +44 (0)20 7827 6093 / Email: mapps@smi-online.co.uk
For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
About Superbugs USA:
Superbugs and Superdrugs USA will take place on 14th & 15th November 2016 in Iselin, New Jersey.
Further information is available at http://www.superbugs-usa.com/openpr
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Teri Arri
Tel: +44 (0)20 7827 6162
Email: tarri@smi-online.co.uk
2 Floor Harling House
47-51 Great Suffolk Street
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Agenda released for SMi’s 19th Annual Superbugs European Show Featuring Keynotes from the FDA, BARDA and GSK here
News-ID: 378096 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Superbugs
Antibiotics Market - Battling Superbugs: Cutting-Edge Antibiotics for Resistant …
Newark, New Castle, USA: The "Antibiotics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Antibiotics Market: https://www.growthplusreports.com/report/antibiotics-market/7752
This latest report researches the industry structure, sales, revenue, price and…
1 week to go to SMi's 22nd Annual Superbugs & Superdrugs Conference
SMi Reports: Superbugs & Superdrugs conference taking place next week, will now be by remote access only
With only 1 week remaining, the 22nd Annual Superbugs & Superdrugs Conference will reconvene on the 30 and 31 March, with remote access only. This year's global focused two-day conference pharmaceutical is for industry professionals looking to gain an in-depth knowledge of the scientific, economic, and regulatory challenges facing the critical global issue of…
Interview with Martin Everett speaker at SMi's Superbugs & Superdrugs Conference
SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi's highly anticipated 22nd Annual Superbugs & Superdrugs Conference on the 30th and 31st March 2020 in London.
This year's global focused two-day conference pharmaceutical is for industry professionals looking to gain an in-depth knowledge of the scientific, economic, and regulatory challenges facing the critical global issue of antibiotic resistance.
For interested individuals to attend…
Evotec & Scynexis to lead the workshops for Superbugs & Superdrugs 2020
SMi Reports: Interactive workshop overview for SMi's 22nd Annual Superbugs & Superdrugs Conference, London in March 2020
SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference will commence on the 30th and 31st March 2020 and in London, UK.
For this year’s conference, industry leaders and key profiles from leading pharmaceutical organisations will be brought together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding…
SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – Speakers Announce …
SMi Reports: the agenda and speaker overview of the upcoming SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view.
SMi Group is delighted to announce the return of the successful Superbugs & Superdrugs Conference for its 22nd year, taking place on 30th and 31st March 2020 at the Holiday Inn Kensington Forum in London. Antibiotics have long been one of the most important pharmaceuticals…
Four weeks until SMi’s 21st Annual Superbugs & Superdrugs Conference 2019
SMi Reports: Senior industry experts will gather in London to discuss the recent advances made in combating antibiotic resistance.
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections.
For this reason, the Superbugs & Superdrugs conference, taking…
